Language in a pandemic-relief bill currently before the U.S. Senate might lead to 340B ceiling prices on some branded drugs being set lower than the drugs’ average manufacturer price (AMP). | Shutterstock
Huge COVID Relief Bill That Would Lift Medicaid Rebate Caps Moves to Senate
The U.S. House on Saturday passed a $1.9 trillion COVID-19 relief bill with language that might lead to 340B ceiling prices on some branded drugs being set lower than the drugs’ average manufacturer price (AMP).
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
